Preventing clinically important deterioration with single-inhaler triple therapy in COPD
Clinically important deterioration (CID) is a novel composite end-point (lung function, health status, exacerbations) for assessing disease stability in patients with chronic obstructive pulmonary disease (COPD). We prospectively analysed CID in the FULFIL study. FULFIL (ClinicalTrials.gov NCT023451...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2018-10-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/4/4/00047-2018.full |